AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19625712 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose peginterferon alfa‐2b (1.0 microg/kg/week) + ribavirin (800-1400 mg/day)
Number of subjects: 3070
Study 19625712 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alfa‐2a (180 microg/week) + ribavirin (1000-1200 mg/day)
Number of subjects: 3070
Study 19625712 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose peginterferon alfa‐2b
Number of subjects: 3070
Study 19625712 — intervention group
Group type: COMPARATOR
Intervention: Low-dose peginterferon alfa‐2b
Number of subjects: 3070
Study 19625712 — intervention group
Group type: COMPARATOR
Intervention: Peginterferon alfa‐2a
Number of subjects: 3070
Study 19625712 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with undetectable HCV RNA levels at treatment weeks 4 and 12
Number of subjects: 3070
Study 17452491 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A injection with 4 sessions of occupational therapy over 4 weeks
Number of subjects: 43
Study 17452491 — intervention group
Group type: COMPARATOR
Intervention: Occupational therapy alone
Number of subjects: 43
Study 15157685 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol/Acetaminophen (APAP) 75 mg/650 mg
Number of subjects: 456
Study 15157685 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg
Number of subjects: 456
Study 15157685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 456
Study 11593710 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion of droperidol 10 mg in 48 hours
Number of subjects: 145
Study 11593710 — intervention group
Group type: COMPARATOR
Intervention: Bolus doses of droperidol 2.5 mg
Number of subjects: 145
Study 11593710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 9689301 — intervention group
Group type: EXPERIMENTAL
Intervention: Ammonium solution
Number of subjects: 25
Study 9689301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 8607936 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg 500 mg/kg/month
Number of subjects: 95
Study 8607936 — intervention group
Group type: COMPARATOR
Intervention: Placebo (albumin)
Number of subjects: 95
Study 2569887 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 0
Study 2569887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1067153 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional mechanical toothcleansing every 2 weeks
Number of subjects: 78
Study 1067153 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 78
Study 30691404 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive cognitive-motor training
Number of subjects: 62
Study 30691404 — intervention group
Group type: COMPARATOR
Intervention: Active control (passive information activity)
Number of subjects: 62
Study 28137517 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkish classical music therapy for 30 minutes daily for 7 days (5 days before and 2 days after labor)
Number of subjects: 70
Study 28137517 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkish classical music therapy
Number of subjects: 70
Study 28137517 — intervention group
Group type: COMPARATOR
Intervention: Routine care and 30 minutes of bed rest daily
Number of subjects: 70
Study 26412309 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertable cardiac monitor (ICM) procedure, Usability study
Number of subjects: 273
Study 26412309 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertable cardiac monitor (ICM) procedure, Registry
Number of subjects: 273
Study 23172402 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) method, N=11, twelve sessions
Number of subjects: 23
Study 23172402 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training with partial body-weight support (TPBWS), N=12, twelve sessions
Number of subjects: 23
Study 21632816 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT)
Number of subjects: 369
Study 21632816 — intervention group
Group type: COMPARATOR
Intervention: Control group (Conventional insulin therapy - CIT)
Number of subjects: 369
Study 20137621 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (IFX) 5 mg/kg body weight at 0, 2, and 6 weeks, followed by maintenance therapy every 8 weeks.
Number of subjects: 8
Study 16961944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 56
Study 14998050 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype power toothbrush (Crest SpinBrush Pro Whitening)
Number of subjects: 20
Study 14998050 — intervention group
Group type: COMPARATOR
Intervention: Positive control power toothbrush (Sonicare Personal 4100)
Number of subjects: 20
Study 11242725 — intervention group
Group type: EXPERIMENTAL
Intervention: DentiPatch (20% lidocaine)
Number of subjects: 32
Study 11242725 — intervention group
Group type: COMPARATOR
Intervention: Topical anesthetic gel (20% benzocaine)
Number of subjects: 32
Study 9133513 — intervention group
Group type: EXPERIMENTAL
Intervention: Angina-guided drug therapy
Number of subjects: 558
Study 9133513 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemia-guided drug therapy
Number of subjects: 558
Study 9133513 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization by angioplasty or bypass surgery
Number of subjects: 558
Study 7595182 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil 1200 mg day‐1
Number of subjects: 20
Study 2213261 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiberoptic blanket (Wallaby Phototherapy System)
Number of subjects: 42
Study 2213261 — intervention group
Group type: COMPARATOR
Intervention: Standard phototherapy unit
Number of subjects: 42
Study 156916 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (0.5 mg, inhalation)
Number of subjects: 0
Study 156916 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (0.25 mg, inhalation)
Number of subjects: 0
Study 156916 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (240 mg, intravenous)
Number of subjects: 0
Study 156916 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglicicum (20 mg, before tests)
Number of subjects: 0
Study 156916 — intervention group
Group type: COMPARATOR
Intervention: Untreated probands
Number of subjects: 0
Study 31546056 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine treatment
Number of subjects: 817
Study 30550498 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom management patient education
Number of subjects: 169
Study 30550498 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 169
Study 28387016 — intervention group
Group type: EXPERIMENTAL
Intervention: SPG neuromodulation
Number of subjects: 300
Study 28912892 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous fingerprint (FP) and high‐wavenumber (HW) fiber‐optic Raman spectroscopy
Number of subjects: 95
Study 28912892 — intervention group
Group type: COMPARATOR
Intervention: Fingerprint (FP) Raman technique alone
Number of subjects: 95
Study 28912892 — intervention group
Group type: COMPARATOR
Intervention: High‐wavenumber (HW) Raman technique alone
Number of subjects: 95
Study 24112947 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills training in addition to TAU
Number of subjects: 119
Study 24112947 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 119
Study 21842428 — intervention group
Group type: EXPERIMENTAL
Intervention: DepoFoam bupivacaine 120 mg
Number of subjects: 193
Study 21842428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 19282306 — intervention group
Group type: EXPERIMENTAL
Intervention: Transluminal endoscopic necrosectomy
Number of subjects: 93
Study 17804986 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitemporal ECT
Number of subjects: 489
Study 17804986 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline plus lithium (continuation pharmacotherapy)
Number of subjects: 489
Study 17804986 — intervention group
Group type: COMPARATOR
Intervention: No melancholic features
Number of subjects: 489
Study 15550321 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture needle manipulation with varying amounts of rotation, downward and upward movement.
Number of subjects: 12
Study 11517739 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibodies to tumor necrosis factor-alpha (anti-TNF-a)
Number of subjects: 30
Study 11517739 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibodies to interferon-gamma (anti-INF-g)
Number of subjects: 30
Study 11517739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 8866937 — intervention group
Group type: EXPERIMENTAL
Intervention: L-threo-3,4-dihydroxyphenylserine (L-DOPS) 100 mg
Number of subjects: 18
Study 8866937 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 18
Study 1323809 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin/etoposide/vincristine (CEV)
Number of subjects: 0
Study 1323809 — intervention group
Group type: COMPARATOR
Intervention: Etoposide/vincristine (Control)
Number of subjects: 0
Study 6209513 — intervention group
Group type: EXPERIMENTAL
Intervention: IVGG
Number of subjects: 85
Study 6209513 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 85
Study 30980923 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 weeks of moderate to high-intensity physical exercise
Number of subjects: 198
Study 30980923 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 weeks of moderate to high-intensity physical exercise in ε4 carriers
Number of subjects: 198
Study 28784273 — intervention group
Group type: EXPERIMENTAL
Intervention: EnligHTN catheter with 4 ablated spots
Number of subjects: 112
Study 28784273 — intervention group
Group type: COMPARATOR
Intervention: Flexability catheter with 4 ablated spots
Number of subjects: 112
Study 28784273 — intervention group
Group type: EXPERIMENTAL
Intervention: EnligHTN catheter with 20 ablated spots
Number of subjects: 112
Study 28784273 — intervention group
Group type: COMPARATOR
Intervention: Flexability catheter with 20 ablated spots
Number of subjects: 112
Study 26506070 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg oxandrolone orally twice daily for 24 months
Number of subjects: 119
Study 26506070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 23912852 — intervention group
Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ) scores <25
Number of subjects: 1465
Study 23912852 — intervention group
Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ) scores >75
Number of subjects: 1465
Study 23912852 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower KCCQ scores
Number of subjects: 1465
Study 22067612 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoghurts containing microencapsulated L. reuteri NCIMB 30242
Number of subjects: 114
Study 22067612 — intervention group
Group type: COMPARATOR
Intervention: Placebo yoghurts
Number of subjects: 114
Study 18629529 — intervention group
Group type: EXPERIMENTAL
Intervention: E (3) - Epidural infusion initiated 3 min after spinal induction
Number of subjects: 144
Study 18629529 — intervention group
Group type: EXPERIMENTAL
Intervention: E (30) - Epidural infusion initiated 30 min after spinal induction
Number of subjects: 144
Study 18629529 — intervention group
Group type: COMPARATOR
Intervention: E (60) - Epidural infusion initiated 60 min after spinal induction
Number of subjects: 144
Study 18629529 — intervention group
Group type: COMPARATOR
Intervention: E (90) - Epidural infusion initiated 90 min after spinal induction
Number of subjects: 144
Study 17932348 — intervention group
Group type: EXPERIMENTAL
Intervention: High plasma carotenoid concentrations
Number of subjects: 207
Study 17932348 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary lycopene
Number of subjects: 207
Study 17932348 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary lutein/zeaxanthin
Number of subjects: 207
Study 15232677 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid regimen (prednisone for 4 months)
Number of subjects: 119
Study 15232677 — intervention group
Group type: COMPARATOR
Intervention: Steroid-free regimen
Number of subjects: 119
Study 15232677 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (steroid-free and steroids)
Number of subjects: 119
Study 12190655 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone (220 micro g twice daily)
Number of subjects: 25
Study 12190655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 9854806 — intervention group
Group type: EXPERIMENTAL
Intervention: Easy secondary task
Number of subjects: 0
Study 9854806 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficult secondary task
Number of subjects: 0
Study 9854806 — intervention group
Group type: EXPERIMENTAL
Intervention: Females under central executive pressure
Number of subjects: 0
Study 9854806 — intervention group
Group type: EXPERIMENTAL
Intervention: Males under central executive pressure
Number of subjects: 0
Study 7796709 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole suspension (100 mg)
Number of subjects: 12
Study 7796709 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole capsule (100 mg)
Number of subjects: 12
Study 2209876 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral micronized estradiol (E2), 2 mg
Number of subjects: 12
Study 2209876 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (Es), 5 mg
Number of subjects: 12
Study 2209876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6451440 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 hour program of activities planned to enable the children to perceive and experience the needs of handicapped people, including stimulations, interactions with handicapped people, and discussions.
Number of subjects: 74
Study 6451440 — intervention group
Group type: COMPARATOR
Intervention: Control group (received a pretest measure of perceptions of handicapped people)
Number of subjects: 74
Study 31427859 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) - low-volume (10 x 60 s at 90% of maximal aerobic velocity interspaced by 60 s at 30% of MAV)
Number of subjects: 17
Study 31427859 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE) - 20 min at 70% of maximum heart rate
Number of subjects: 17
Study 31427859 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise) - 25 min in a seated position
Number of subjects: 17
Study 28236335 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercept pathogen-reduction technology
Number of subjects: 424
Study 28236335 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirasol pathogen-reduction technology
Number of subjects: 424
Study 28236335 — intervention group
Group type: COMPARATOR
Intervention: Standard platelets (control)
Number of subjects: 424
Study 25479112 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope video laryngoscopy
Number of subjects: 117
Study 25479112 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 117
Study 25699348 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 60
Study 25699348 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 60
Study 21087238 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuronox
Number of subjects: 119
Study 21087238 — intervention group
Group type: COMPARATOR
Intervention: BOTOX
Number of subjects: 119
Study 19023897 — intervention group
Group type: EXPERIMENTAL
Intervention: IVRS administration of SIBDQ
Number of subjects: 64
Study 19023897 — intervention group
Group type: EXPERIMENTAL
Intervention: IVRS administration of SIBDQ in active CD
Number of subjects: 64
Study 19023897 — intervention group
Group type: EXPERIMENTAL
Intervention: IVRS administration of SIBDQ in active UC
Number of subjects: 64
Study 19023897 — intervention group
Group type: EXPERIMENTAL
Intervention: IVRS administration of SIBDQ (first vs second administration)
Number of subjects: 64
Study 17517761 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid based cytology
Number of subjects: 45174
Study 17517761 — intervention group
Group type: COMPARATOR
Intervention: Conventional cytology
Number of subjects: 45174
Study 15489585 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon + ribavirin
Number of subjects: 163
Study 15489585 — intervention group
Group type: COMPARATOR
Intervention: Interferon
Number of subjects: 163
Study 11403532 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs), specifically esomeprazole at 40 mg
Number of subjects: 0
Study 11403532 — intervention group
Group type: COMPARATOR
Intervention: H2-receptor antagonists
Number of subjects: 0
Study 11403532 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs)
Number of subjects: 0
Study 11403532 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of proton pump inhibitors
Number of subjects: 0
Study 9661803 — intervention group
Group type: EXPERIMENTAL
Intervention: Temocapril, 2 to 4 mg once daily for 12 months
Number of subjects: 63
Study 9661803 — intervention group
Group type: COMPARATOR
Intervention: CCBs (nitrendipine, nisoldipine, or amlodipine) continued for 12 months
Number of subjects: 63
Study 8146105 — intervention group
Group type: EXPERIMENTAL
Intervention: 414 mg nitrate + nitrite and 23 mg vitamin C
Number of subjects: 12
Study 8146105 — intervention group
Group type: EXPERIMENTAL
Intervention: 412 mg nitrate + nitrite and 177 mg vitamin C
Number of subjects: 12
Study 8146105 — intervention group
Group type: EXPERIMENTAL
Intervention: 23 mg nitrate + nitrite and 39 mg vitamin C
Number of subjects: 12
Study 8146105 — intervention group
Group type: EXPERIMENTAL
Intervention: 21 mg nitrate + nitrite and 193 mg vitamin C
Number of subjects: 12
Study 8146105 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intake of vitamin C at either level of nitrate + nitrite intake
Number of subjects: 12
Study 2438222 — intervention group
Group type: EXPERIMENTAL
Intervention: PVeBV (cisplatin, vinblastine, bleomycin, VP-16)
Number of subjects: 0
Study 2438222 — intervention group
Group type: COMPARATOR
Intervention: PVeB (cisplatin, vinblastine, bleomycin)
Number of subjects: 0
Study 31823047 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic spleen-preserving D2 total gastrectomy (LSTG)
Number of subjects: 242
Study 30336390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use 12x/month or more during treatment
Number of subjects: 1205
Study 30336390 — intervention group
Group type: COMPARATOR
Intervention: Cannabis abstinence
Number of subjects: 1205
Study 30336390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use (1x/month, 1-2x/month, 4-8x/month)
Number of subjects: 1205
Study 28699427 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment to reinstate euthyroidism
Number of subjects: 10
Study 25053508 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-packing
Number of subjects: 14
Study 25053508 — intervention group
Group type: COMPARATOR
Intervention: Packing
Number of subjects: 14
Study 22665103 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement (QI) intervention including educational materials for clinicians, reminders, algorithms, and case manager training
Number of subjects: 1150
Study 22665103 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement (QI) intervention
Number of subjects: 1150
Study 22665103 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine practice)
Number of subjects: 1150
Study 20485969 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper group
Number of subjects: 90
Study 20485969 — intervention group
Group type: EXPERIMENTAL
Intervention: K3 group
Number of subjects: 90
Study 20485969 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtwo group
Number of subjects: 90
Study 20485969 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 17368342 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA with ultrasonics (Group C)
Number of subjects: 75
Study 17368342 — intervention group
Group type: COMPARATOR
Intervention: 17% EDTA (Group B)
Number of subjects: 75
Study 17368342 — intervention group
Group type: COMPARATOR
Intervention: Smear Clear (Group D)
Number of subjects: 75
Study 17368342 — intervention group
Group type: COMPARATOR
Intervention: Smear Clear with ultrasonics (Group E)
Number of subjects: 75
Study 15698513 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI) co-therapy for 6 months
Number of subjects: 30
Study 15698513 — intervention group
Group type: COMPARATOR
Intervention: Chronic COX-2 therapy
Number of subjects: 30
Study 15698513 — intervention group
Group type: COMPARATOR
Intervention: Chronic NSAID therapy
Number of subjects: 30
Study 15698513 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study 11999607 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation anaesthesia with desflurane or sevoflurane
Number of subjects: 102
Study 11999607 — intervention group
Group type: COMPARATOR
Intervention: Propofol administered by target controlled infusion
Number of subjects: 102
Study 9674667 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite compliance index (unweighted)
Number of subjects: 2736
Study 9674667 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite compliance index (weighted)
Number of subjects: 2736
Study 9674667 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite compliance index (statistically weighted)
Number of subjects: 2736
Study 9674667 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary isoniazid metabolite testing
Number of subjects: 2736
Study 9674667 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic attendance
Number of subjects: 2736
Study 9674667 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report
Number of subjects: 2736
Study 9674667 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding of the regimen, study arm, subsequent follow-up, tuberculosis status, and urine spot-check result
Number of subjects: 2736
Study 10155331 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin 6000U weekly for 2 months
Number of subjects: 0
Study 10155331 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin 9000U weekly for 2 months
Number of subjects: 0